Cargando…

Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction

OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Esben Søvsø Szocska, Pedersen, Steen Fjord, Pedersen, Steen Bønløkke, Kjærgaard, Uffe, Schmidt, Nikolaj Hjort, Bøtker, Hans Erik, Kim, Won Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838761/
https://www.ncbi.nlm.nih.gov/pubmed/27110375
http://dx.doi.org/10.1136/openhrt-2015-000346
_version_ 1782428027560394752
author Hansen, Esben Søvsø Szocska
Pedersen, Steen Fjord
Pedersen, Steen Bønløkke
Kjærgaard, Uffe
Schmidt, Nikolaj Hjort
Bøtker, Hans Erik
Kim, Won Yong
author_facet Hansen, Esben Søvsø Szocska
Pedersen, Steen Fjord
Pedersen, Steen Bønløkke
Kjærgaard, Uffe
Schmidt, Nikolaj Hjort
Bøtker, Hans Erik
Kim, Won Yong
author_sort Hansen, Esben Søvsø Szocska
collection PubMed
description OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) and T2 weighted short tau inversion recovery (T2-STIR) imaging have been used to detect IMH and to explore its clinical importance. IMH is typically identified within the area-at-risk as a hypointense signal core on T2-STIR images. Because MVO will also appear as a hypointense signal core, T2-STIR imaging may not be an optimal method for assessing IMH. In this study, we sought to investigate the ability of T2-STIR to discriminate between MVO with IMH in a porcine myocardial ischaemia-reperfusion model that expressed MVO with and without IMH. METHOD: MVO with and without IMH (defined from both macroscopic evaluation and T1 weighted CMR) was produced in 13 pigs by a 65-min balloon occlusion of the mid left anterior descending artery, followed by reperfusion. Eight days after injury, all pigs underwent CMR imaging and subsequently the hearts were assessed by gross pathology. RESULTS: CMR identified MVO in all hearts. CMR and pathology showed that IMH was present in 6 of 13 (46%) infarcts. The sensitivity and specificity of T2-STIR hypointense signal core for identification of IMH was 100% and 29%, respectively. T2-values between hypointense signal core in the pigs with and without IMH were similar (60.4±3 ms vs 63.0±4 ms). CONCLUSIONS: T2-STIR did not allow identification of IMH in areas with MVO in a porcine model of myocardial ischaemic/reperfusion injury in the subacute phase of a reperfused myocardial infarction.
format Online
Article
Text
id pubmed-4838761
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48387612016-04-22 Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction Hansen, Esben Søvsø Szocska Pedersen, Steen Fjord Pedersen, Steen Bønløkke Kjærgaard, Uffe Schmidt, Nikolaj Hjort Bøtker, Hans Erik Kim, Won Yong Open Heart Basic and Translational Research OBJECTIVE: Microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH) are known complications of myocardial ischaemia-reperfusion injury. Whereas MVO is an established marker for a poor clinical outcome, the clinical significance of IMH remains less well defined. Cardiovascular MR (CMR) and T2 weighted short tau inversion recovery (T2-STIR) imaging have been used to detect IMH and to explore its clinical importance. IMH is typically identified within the area-at-risk as a hypointense signal core on T2-STIR images. Because MVO will also appear as a hypointense signal core, T2-STIR imaging may not be an optimal method for assessing IMH. In this study, we sought to investigate the ability of T2-STIR to discriminate between MVO with IMH in a porcine myocardial ischaemia-reperfusion model that expressed MVO with and without IMH. METHOD: MVO with and without IMH (defined from both macroscopic evaluation and T1 weighted CMR) was produced in 13 pigs by a 65-min balloon occlusion of the mid left anterior descending artery, followed by reperfusion. Eight days after injury, all pigs underwent CMR imaging and subsequently the hearts were assessed by gross pathology. RESULTS: CMR identified MVO in all hearts. CMR and pathology showed that IMH was present in 6 of 13 (46%) infarcts. The sensitivity and specificity of T2-STIR hypointense signal core for identification of IMH was 100% and 29%, respectively. T2-values between hypointense signal core in the pigs with and without IMH were similar (60.4±3 ms vs 63.0±4 ms). CONCLUSIONS: T2-STIR did not allow identification of IMH in areas with MVO in a porcine model of myocardial ischaemic/reperfusion injury in the subacute phase of a reperfused myocardial infarction. BMJ Publishing Group 2016-04-20 /pmc/articles/PMC4838761/ /pubmed/27110375 http://dx.doi.org/10.1136/openhrt-2015-000346 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Basic and Translational Research
Hansen, Esben Søvsø Szocska
Pedersen, Steen Fjord
Pedersen, Steen Bønløkke
Kjærgaard, Uffe
Schmidt, Nikolaj Hjort
Bøtker, Hans Erik
Kim, Won Yong
Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title_full Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title_fullStr Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title_full_unstemmed Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title_short Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
title_sort cardiovascular mr t2-stir imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction
topic Basic and Translational Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838761/
https://www.ncbi.nlm.nih.gov/pubmed/27110375
http://dx.doi.org/10.1136/openhrt-2015-000346
work_keys_str_mv AT hansenesbensøvsøszocska cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT pedersensteenfjord cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT pedersensteenbønløkke cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT kjærgaarduffe cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT schmidtnikolajhjort cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT bøtkerhanserik cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction
AT kimwonyong cardiovascularmrt2stirimagingdoesnotdiscriminatebetweenintramyocardialhaemorrhageandmicrovascularobstructionduringthesubacutephaseofareperfusedmyocardialinfarction